FDA Rush To Create Pediatric Drug List Compromised Policy - Generic Firms
Executive Summary
FDA's push to meet the statutory deadline for its pediatric list did not permit adequate public input and resulted in too broad a list of drugs for which innovator companies may gain exclusivity, generic groups asserted in a lawsuit filed in D.C. federal court Feb. 19.